- Forums
- ASX - By Stock
- artimist has 2.5x bioavailablity of oral
Phase III report due January 2013
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMS (ASX) to my watchlist